QVT Associates GP LLC, 10% Owner at Urovant Sciences Ltd. (UROV), bought 35,176 shares at $8.58 ($292K) on 2019-06-11, disclosed to the SEC on 2019-06-11.
Open-market purchase of $292k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 6,649 | $53K | 18.1% |
| 2 | $7.97 | 6,649 | $53K | 18.1% |
| 3 | $8.35 | 7,500 | $63K | 21.4% |
| 4 | $8.58 | 7,189 | $62K | 21.1% |
| 5 | $8.58 | 7,189 | $62K | 21.1% |
| Total | $8.30 avg | 35,176 |
| $292K |
| 100% |
| Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $326K | — | Filing → |
| UROV | BUY | 2019-05-20 | $326K | — | Filing → |